Naturhouse Health (Germany) Performance
| 2NH Stock | EUR 1.74 0.02 1.16% |
Naturhouse Health has a performance score of 5 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.2, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Naturhouse Health are expected to decrease at a much lower rate. During the bear market, Naturhouse Health is likely to outperform the market. Naturhouse Health right now secures a risk of 2.15%. Please verify Naturhouse Health SA total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to decide if Naturhouse Health SA will be following its current price movements.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Naturhouse Health SA are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Naturhouse Health may actually be approaching a critical reversion point that can send shares even higher in March 2025. ...more
| Begin Period Cash Flow | 21.6 M | |
| Total Cashflows From Investing Activities | -4.3 M |
Naturhouse |
Naturhouse Health Relative Risk vs. Return Landscape
If you would invest 162.00 in Naturhouse Health SA on November 28, 2024 and sell it today you would earn a total of 12.00 from holding Naturhouse Health SA or generate 7.41% return on investment over 90 days. Naturhouse Health SA is currently producing 0.1416% returns and takes up 2.1477% volatility of returns over 90 trading days. Put another way, 19% of traded stocks are less volatile than Naturhouse, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Naturhouse Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Naturhouse Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Naturhouse Health SA, and traders can use it to determine the average amount a Naturhouse Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0659
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | 2NH | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.15 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Naturhouse Health is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Naturhouse Health by adding it to a well-diversified portfolio.
Naturhouse Health Fundamentals Growth
Naturhouse Stock prices reflect investors' perceptions of the future prospects and financial health of Naturhouse Health, and Naturhouse Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Naturhouse Stock performance.
| Return On Equity | 0.38 | |||
| Return On Asset | 0.19 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 79.91 M | |||
| Shares Outstanding | 59.95 M | |||
| Price To Earning | 8.66 X | |||
| Price To Book | 3.07 X | |||
| Price To Sales | 1.68 X | |||
| Revenue | 57.59 M | |||
| EBITDA | 20.8 M | |||
| Cash And Equivalents | 16.1 M | |||
| Cash Per Share | 0.27 X | |||
| Total Debt | 11.47 M | |||
| Debt To Equity | 49.10 % | |||
| Book Value Per Share | 0.51 X | |||
| Cash Flow From Operations | 16.17 M | |||
| Earnings Per Share | 0.19 X | |||
| Total Asset | 49 M | |||
About Naturhouse Health Performance
By analyzing Naturhouse Health's fundamental ratios, stakeholders can gain valuable insights into Naturhouse Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Naturhouse Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Naturhouse Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Naturhouse Health, S.A. operates in the nutrition and weight management industry in Spain and internationally. The company was founded in 1991 and is based in Madrid, Spain. Naturhouse Health operates under Personal Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 588 people.Things to note about Naturhouse Health performance evaluation
Checking the ongoing alerts about Naturhouse Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Naturhouse Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Naturhouse Health may become a speculative penny stock | |
| About 78.0% of the company shares are owned by insiders or employees |
- Analyzing Naturhouse Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Naturhouse Health's stock is overvalued or undervalued compared to its peers.
- Examining Naturhouse Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Naturhouse Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Naturhouse Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Naturhouse Health's stock. These opinions can provide insight into Naturhouse Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Naturhouse Stock analysis
When running Naturhouse Health's price analysis, check to measure Naturhouse Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Naturhouse Health is operating at the current time. Most of Naturhouse Health's value examination focuses on studying past and present price action to predict the probability of Naturhouse Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Naturhouse Health's price. Additionally, you may evaluate how the addition of Naturhouse Health to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |